Lawrence Brandt, MD
Gastroenterology · Bronx, NYNPI 1477643369
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,670 of the $20,761 with a category attached, or 85.1%. Ferring Pharmaceuticals Inc. accounts for 94.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $19,880 and has fallen 98.6% since, to $280 in 2025.
Across 35 payments — averaging $593.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$20K
- Olympus America Inc.$913
- Takeda Pharmaceuticals U.S.A., Inc.$89
- Boston Scientific$33
- Exact Sciences$32
- Celltrion USA Inc.$26
- plus $76 from 4 others
Across 1 payment — averaging $5152.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$5K
What the payments were for
- Consulting fees$17,67085%
- Travel & lodging$1,4307%
- Food & beverage$1,6618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 15 | $19,591 |
| Olympus America Inc. | 9 | $913 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Boston Scientific | 1 | $33 |
| Exact Sciences | 1 | $32 |
| Celltrion USA Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBYOTA$19,276
- EndoClot SIS$246
- EndoClot PHS$193
- Single Use Repositionable Clip$143
- VISIGLIDE$117
How this compares
$20,761 in reported general payments places this provider in the 85th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bronx
- David SteinBronx$196K
- Sammy HoBronx$195K
- Vivek GumasteBronx$139K
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.